Thus, RUNX3 broadly influences immune signal output through transcriptional regulatory pathways, potentially playing a central role in maintaining tumor–myeloid cell interactions and providing potential intervention strategies for targeting the RUNX3–MP interaction axis. Here, PPP1CB is linked to neoplasm.